Esperion Therapeutics Inc (ESPR)

Add to Watchlists
Create an Alert
40.94 +0.84  +2.09% NASDAQ Apr 18, 20:00 Delayed 2m USD
View Full Chart
ESPR Price Chart
View All Events

ESPR Events

Date Type Description
03/04/2019 Earnings Esperion Therapeutics Inc Fourth Quarter Earnings Results in 2018
11/01/2018 Earnings Esperion Therapeutics Inc Third Quarter Earnings Results in 2018
08/02/2018 Earnings Esperion Therapeutics Inc Second Quarter Earnings Results in 2018
07/10/2018 Misc Esperion to Host Analyst and Investor Day Event on July 10
05/02/2018 Earnings Esperion Therapeutics Inc First Quarter Earnings Results in 2018
View All Performance Charts

ESPR Total Returns Comparison


ESPR One Page Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: Michigan
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: N/A
  • Last Earnings Release: Mar. 04, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm has Business of researching, developing and commercializing therapies for the treatment of patients with the elevated LDL-C operating segment.

ESPR Comparables


ESPR Excel Add-In Codes

  • Name: =YCI("ESPR","name")
  • Description: =YCI("ESPR","description")
  • Sector: =YCI("ESPR","sector")
  • Industry: =YCI("ESPR","industry")
  • Est. Current Fiscal Year End: =YCI("ESPR","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.